Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells.
about
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Pharmacological targeting of t ...... ryonal rhabdomyosarcoma cells.
@en
Pharmacological targeting of t ...... ryonal rhabdomyosarcoma cells.
@nl
type
label
Pharmacological targeting of t ...... ryonal rhabdomyosarcoma cells.
@en
Pharmacological targeting of t ...... ryonal rhabdomyosarcoma cells.
@nl
prefLabel
Pharmacological targeting of t ...... ryonal rhabdomyosarcoma cells.
@en
Pharmacological targeting of t ...... ryonal rhabdomyosarcoma cells.
@nl
P2093
P2860
P50
P1476
Pharmacological targeting of t ...... bryonal rhabdomyosarcoma cells
@en
P2093
Carlo Dominici
Cinzia Marchese
Claudio Festuccia
Ellen Van der Aar
Filip Beirinckx
Francesca De Felice
Francesca Megiorni
Giovanni Luca Gravina
Heather P McDowell
Laurent Saniere
P2860
P2888
P356
10.1186/S13045-017-0530-Z
P50
P577
2017-10-06T00:00:00Z
P6179
1092113735